Linked Life Data

3064779

Source:http://linkedlifedata.com/resource/pubmed/id/3064779

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6A
pubmed:dateCreated
1989-3-23
pubmed:abstractText
The interest in cost calculations of medical treatment programs has increased during the last decade. In the Danish Breast Cancer Cooperative Group's (DBCG) protocol 77B, 1,028 premenopausal patients were randomized after mastectomy to radiotherapy (RT) alone (control), RT + 12 cycles of cyclophosphamide (C) or to RT + 12 cycles of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). This study analyzes the costs associated with systemic treatment and follow-up programs in the 3 regimens. Costs connected with the primary mastectomy and the radiotherapy, which were identical in the 3 regimens, have not been included in the analysis. The analysis shows that the expenses for the postoperative treatment and follow-up program for 9 years in the control regimen are 8,250 DKK, whereas the costs for the C regimen are 11,000 DKK, and the costs for the CMF regimen are 18,000 DKK.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0284-186X
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
767-71
pubmed:dateRevised
2009-5-12
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Treatment costs of adjuvant cytotoxic therapy in premenopausal breast cancer patients.
pubmed:affiliation
Department of Oncology ONA, Finsen Institute, Rigshospitalet, Copenhagen, Denmark.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial